FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended June 30, 1997

Commission File Number 1-8635

                          AMERICAN MEDICAL ALERT CORP.
        (Exact Name of Small Business Issuer as Specified in its Charter)

           New York                                              11-2571221
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                            Identification Number)

                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
                (Issuer's telephone number, including area code)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act of 1934  during the  preceding  12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days. Yes [X]   No [_]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  5,896,720 shares of $.01 par
value common stock as of August 1, 1997.


<PAGE>



                          AMERICAN MEDICAL ALERT CORP.
                                      INDEX


                          PART I FINANCIAL INFORMATION

                                                                            PAGE

Item 1.              Financial Statements.
                     Condensed Balance Sheets for June 30, 1997
                     and December 31, 1996                                    1

                     Condensed Statements of Income for the
                     Six Months Ended June 30, 1997 and 1996                  2

                     Condensed Statements of Income for the
                     Three Months Ended June 30, 1997 and 1996                3

                     Condensed Statements of Cash Flows for
                     the Six Months Ended June 30, 1997 and 1996              4

                     Notes to Condensed Financial Statements                  5

Item 2.              Management's Discussion and Analysis of
                     Financial Condition and Results of Operations.           6


                            PART II OTHER INFORMATION


Item 4.              Submission of Matters to a Vote of Security-Holders.     7

Item 6.              Exhibits and Reports on Form 8-K.                        9



<PAGE>



Item 1.    Financial Statements.

                          AMERICAN MEDICAL ALERT CORP.
                            CONDENSED BALANCE SHEETS

<TABLE>
<CAPTION>
                                     ASSETS
                                                                   June 30, 1997  Dec.,31,1996*
                                                                    (UNAUDITED
                                                                    -----------    -----------
<S>                                                                 <C>            <C>        
CURRENT ASSETS:
           Cash                                                     $   231,320    $   301,013
           Accounts and notes receivable (net of allowance
           for doubtful accounts of $30,000 in each of '97 & '96)     1,532,267      1,327,799
           Inventory                                                  1,170,278      1,171,021
           Prepaid expenses and other current assets                    308,754        137,247
           Deferred income tax benefit                                   54,000         54,000
                                                                    -----------    -----------

Total Current Assets                                                  3,296,619      2,991,080
                                                                    -----------    -----------
           Inventory of medical devices held for lease at cost          547,000        637,000
                                                                    -----------    -----------
           Note receivable                                                  -0-         15,956
                                                                    -----------    -----------

FIXED ASSETS:
           (Net of accumulated depreciation and amortization)         3,226,877      3,115,110

OTHER ASSETS                                                             25,692         24,868
                                                                    -----------    -----------


TOTAL ASSETS                                                        $ 7,096,188    $ 6,784,014
                                                                    ===========    ===========


                      LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
           Note Payable Bank                                        $   450,000    $       -0-
           Accounts payable                                             186,505        192,707
           Accrued expenses                                             171,182        311,954
           Taxes payable                                                    -0-         16,464
           Current portion of long-term debt                              9,332          9,182
                                                                    -----------    -----------
Total Current Liabilities                                               817,019        530,307

DEFERRED INCOME TAX LIABILITY                                           258,000        258,000
NOTE PAYABLE BANK                                                           -0-        450,000
LONG-TERM DEBT-LESS CURRENT MATURITIES                                    7,244         11,849
                                                                    -----------    -----------
Total Liabilities                                                     1,082,263      1,250,156
                                                                    -----------    -----------

COMMITMENTS AND CONTINGENT LIABILITIES
SHAREHOLDERS' EQUITY
           Preferred stock - $.01 par value;                                -0-            -0-
              authorized - 1,000,000 shares -
              none issued and outstanding 
           Common stock - $.01 par value;                                58,878         58,432
              authorized - 10,000,000 shares; issued
              and outstanding - 5,887,752 shares in
              1997 and 5,843,276 shares in 1996 
           Additional paid-in capital                                 4,483,484      4,391,990
           Retained Earnings                                          1,577,595      1,189,468
                                                                    -----------    -----------
                                                                      6,119,957      5,639,890

            Less 43,910 shares in 1997 & 1,995 in 1996 of              (106,032)      (106,032)
            treasury stock, at cost                                 -----------    -----------


           Total Shareholders Equity                                  6,013,925      5,533,858
                                                                    -----------    -----------

TOTAL LIABILITIES & SHAREHOLDERS EQUITY                             $ 7,096,188    $ 6,784,014
                                                                    ===========    ===========
</TABLE>

See accompanying notes to condensed financial statements.
* Derived from audited financial statements

                                        1

<PAGE>



                          AMERICAN MEDICAL ALERT CORP.
                         CONDENSED STATEMENTS OF INCOME
                                   (Unaudited)


                                                      Six Months Ended June 30,
                                                        1997           1996
                                                     -----------    -----------

Revenues:
           Services                                  $ 3,284,793    $ 3,014,028
           Product Sales                                 291,893        508,988
                                                     -----------    -----------
                                                       3,576,686      3,523,016
                                                     -----------    -----------

Cost and Expenses (Income):
           Costs related to services (Note 4)          1,233,608      1,012,304
           Costs of products sold (Note 4)               270,419        347,046
           Selling, general and
           administrative expenses                     1,355,578      1,251,171
           Interest expense                               23,934         25,236
Other income                                                (680)        (1,000)
                                                     -----------    -----------
                                                       2,882,859      2,634,757
                                                     -----------    -----------

Income before provision for income taxes                 693,827        888,259

Provision for income taxes                               305,700        391,000
                                                     -----------    -----------

NET INCOME                                           $   388,127    $   497,259
                                                     -----------    -----------

Net income per share                                 $       .07    $       .09
                                                     ===========    ===========
Weighted average number of
common shares outstanding (Note 3)                     5,918,128      5,765,456
                                                     ===========    ===========

See accompanying notes to condensed financial statements


                                        2


<PAGE>

<PAGE>





                          AMERICAN MEDICAL ALERT CORP.

                         CONDENSED STATEMENTS OF INCOME
                                   (Unaudited)


                                                    Three Months Ended June 30,
                                                    ---------------------------
                                                       1997            1996
                                                    -----------     -----------
Revenues:
           Services                                 $ 1,669,028     $ 1,534,772
           Product Sales                                177,318         337,098
                                                    -----------     -----------
                                                      1,846,346       1,871,870

Cost and Expenses (Income):
           Cost related to services (Note 4)            642,316         537,591
           Costs of products sold (Note 4)              163,020         236,595
           Selling, general and
           administrative expenses                      650,759         605,375
           Interest expense                              11,104          10,125

           Other Income                                    (334)         (1,000)
                                                    -----------     -----------
                                                      1,466,865       1,388,686
                                                    -----------     -----------
Income before provisions for income
taxes                                                   379,481         483,184

Provision for income taxes                              166,700         213,000
                                                    -----------     -----------


NET INCOME                                          $   212,781     $   270,184
                                                    ===========     ===========

Net income per share                                $       .04     $       .05
                                                    ===========     ===========
Weighted average number of
common shares outstanding (Note 3)                    5,936,156     $ 5,788,124
                                                    ===========     ===========
                                                                             
                                                                             
                                                                             
See accompanying notes to condensed financial statements

                                        3


<PAGE>



                          AMERICAN MEDICAL ALERT CORP.

                        CONDENSED STATEMENT OF CASH FLOWS
                                   (Unaudited)

                                                       Six Months Ended June 30,
                                                       -------------------------
                                                           1997         1996
                                                         ---------    ---------

Cash Flows From Operating Activities:
     Net Income                                          $ 388,127    $ 497,259

     Adjustments to reconcile net income to
      net cash provided by operating activities

     Provision for deferred  income taxes                   24,000
     Depreciation  and  amortization                       357,580      308,102
     Change in Assets and Liabilities:
     (Increase) Decrease in receivables                   (204,468)    (106,294)
     (Increase) Decrease in inventory                       90,743     (188,767)
     (Increase) in prepaid expenses
       and other assets                                   (156,375)     (42,543)
     Increase (Decrease) in accounts payable,
       accrued expenses and taxes payable                 (163,438)      71,444
                                                         ---------    ---------

Net Cash Provided by Operating Activities                  312,169      563,201
                                                         ---------    ---------

Cash Flows from Investing Activities:
     Expenditures for fixed assets                        (469,347)    (500,349)
                                                         ---------    ---------

Net Cash Used In Investing Activities                     (469,347)    (500,349)
                                                         ---------    ---------
Cash Flows from Financing Activities:
     Repayment of bank borrowing                             - 0 -     (150,000)
     Net (Repayment of) loans payable                       (4,455)      10,654
Net Proceeds upon exercise of stock options                 91,940        7,536
                                                         ---------    ---------

Net Cash Provided (Used) in Financing Activities            87,485     (131,810)
                                                         ---------    ---------

Net (Decrease) increase in Cash                            (69,693)     (68,958)
Cash, Beginning of Period                                  301,013      319,989
                                                         ---------    ---------
Cash, End of Period                                      $ 231,320    $ 251,031
                                                         =========    =========


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

CASH PAID DURING THE PERIOD
FOR INTEREST                                             $  23,934    $  25,236
                                                         =========    =========

CASH PAID DURING THE PERIOD
FOR INCOME TAXES                                         $ 390,177    $ 207,129
                                                         =========    =========


See accompanying notes to condensed financial statements


                                        4


<PAGE>





                          AMERICAN MEDICAL ALERT CORP.

                     Notes to Condensed Financial Statements
                                   (Unaudited)

1.         General:

           These  financial  statements  should be read in conjunction  with the
           notes to the  financial  statements  contained  in the latest  annual
           report on Form 10-KSB for the year ended December 31, 1996.



2.         Results of Operations:

           In the opinion of management,  the accompanying  unaudited  condensed
           financial  statements  contain all  adjustments  (consisting  only of
           normal recurring  accruals) necessary to present fairly the financial
           position as of June 30, 1997, the condensed  statements of income for
           the three and six month periods ended June 30, 1997 and 1996, and the
           statements  of cash flows for the six months  ended June 30, 1997 and
           1996. These financial  statements  should be read in conjunction with
           the  financial  statements  and  notes  thereto  for the  year  ended
           December 31, 1996  included in the  Company's  Annual  Report on Form
           10-KSB.  The accounting  policies used in preparing  these  financial
           statements are consistent with those applied in the December 31, 1996
           financial statements.



3.         Income Per Share:

           In February 1997,  the Financial  Accounting  Standards  Board issued
           Statement  of  Financial   Accounting  Standards  ("SFAS")  No.  128,
           "Earnings per Share" which  changes the  methodology  of  calculating
           earnings per share.  SFAS No. 128 requires the  disclosure of diluted
           earnings per share  regardless of its difference  from basic earnings
           per share.  The company plans to adopt SFAS No. 128 in December 1997.
           Early adoption is not permitted. Had the company adopted SFAS No. 128
           as of June 30, 1997, the related per share  disclosure for both basic
           and diluted earnings per share would have been:

                Three Months Ended June 30            Six Months Ended June 30
                --------------------------            ------------------------
                      Basic     Diluted                   Basic     Diluted
                      -----     -------                   -----     -------
                                                   
             1997       .04         .04                    .07          .07
                    =======     =======                =======      =======
                                                   
             1996       .05         .05                    .10          .09
                    =======     =======                =======      =======
                                                
                                        5


<PAGE>



                          AMERICAN MEDICAL ALERT CORP.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                    (for the Six Months Ended June 30, 1997)

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report on Form 10-KSB dated December 31, 1996.

Liquidity and Capital Resources
-------------------------------

On March 27, 1997, the Company  renegotiated  its $ 1,500,000 credit note (based
upon 75% of eligible accounts  receivable and 25% of inventory,  as defined) and
extended it until April 30, 1998. As of July 28, 1997, $ 350,000 was outstanding
under this note. The Company's working capital on June 30, 1997 was $ 2,451,315.
During 1997 the Company  anticipates  that it will make capital  investments  of
approximately  $ 1,000,000 of which  approximately  $ 470,000 has been  expended
through June 30, 1997 for the  purchase and  production  of  additional  systems
which the Company  intends to rent.  The Company  believes that its present cash
and working capital position,  its borrowing availability and future anticipated
income will be  sufficient  to meet its cash and working  capital  needs for the
foreseeable future.

Results of Operations
---------------------

Revenue from services increased $ 270,765 for the six months ended June 30, 1997
as  compared  to the same  period in 1996,  an  increase  of 9%.  This  increase
resulted  from  the  expansion  of  the  Company's  customer  base  for  monthly
monitoring  and leasing  services.  Costs related to services for the six months
ended June 30, 1997 and 1996 were 38% and 34% respectively.

Revenue  from  services  increased $ 134,256 for the three months ended June 30,
1997 as compared to the same  period in 1996,  an increase of 9%. This  increase
resulted  from  the  expansion  of  the  Company's  customer  base  for  monthly
monitoring and leasing services.  Costs related to services for the three months
ended June 30, 1997 and 1996 were 38% and 35% respectively.

Revenue from product sales decreased $ 217,095 for the six months ended June 30,
1997 as compared to the same period in 1996,  a decrease of 43%.  This  decrease
was primarily due to the  rescheduling  of sales to retirement  communities  and
assisted living facilities. The gross profit on product sales for the six months
ended June 30, 1997 and 1996 was 7% and 32% respectively.

Revenue from product  sales  decreased $ 159,780 for the three months ended June
30,  1997 as  compared  to the same  period in 1996,  a  decrease  of 47%.  This
decrease  was  primarily  due  to  the   rescheduling  in  sales  to  retirement
communities  and assisted living  facilities.  The gross profit on product sales
for the three months  ended June 30, 1997 and 1996 was 8% and 30%  respectively.
This decline was  attributable  to increased  fixed  production  costs and sales
concessions made to a major new customer.

                                        6


<PAGE>



As a result of these concessions,  a contract to purchase significant quantities
of new product was achieved.

Interest  expense  for the six months  ended June 30, 1997 and 1996 was $ 23,934
and $ 25,236  respectively.  Selling,  general  and  administrative  expenses as
compared as a  percentage  of total  revenues  for the six months ended June 30,
1997 and 1996 were 38% and 36% respectively.

Interest  expense for the three months ended June 30, 1997 and 1996 was $ 11,104
and  $10,125  respectively.  Selling,  general  and  administrative  expenses as
compared as a percentage  of total  revenues for the three months ended June 30,
1997 and 1996 were 35% and 32% respectively.

                          PART II. - OTHER INFORMATION

Item 4.  Submission of matters to a Vote of Security Holders.

On June 11, 1997, the Company held its 1997 Annual Meeting of Shareholders  (the
"1997 Meeting").

At the 1997 Meeting, the Company's  shareholders elected five directors to serve
until  the 1998  Annual  Meeting  of  Shareholders  and until  their  respective
successors  shall be elected and  qualified.  The vote for such directors was as
follows:

                                                      FOR               WITHHELD
                                                      ---               --------

Howard M. Siegel                                   4,981,207             57,087
Myron Segal                                        4,981,107             57,187
Leonard Herz                                       4,981,207             57,087
Peter Breitstone                                   4,981,207             57,087
Eli S. Feldman                                     4,981,207             57,087

The proposal to amend the Corporation's Certificate of Incorporation to increase
the total number of shares of capital stock which the  Corporation has authority
to issue from 10,000,000 to 11,000,000 and to create a class of stock designated
as  preferred  stock with a par value of $ .01 per share which would  consist of
1,000,000  shares,  received  the  affirmative  vote of a majority of the shares
issued, outstanding and entitled to vote thereon.

The proposal  authorizing that 750,000 shares of the Corporation's  Common Stock
be reserved for the issuance  upon the exercise of options  being  granted under
the American Medical Alert 1997 Stock Option Plan was approved.

The Company's  shareholders  voted with respect to the ratification and approval
of Margolin,  Winer & Evens, LLP as the Company's  independent  auditors for the
year ending December 31, 1997.  Approximately 98% of the votes cast with respect
to the ratification and approval voted in favor of the proposal and accordingly,
the proposal was approved.


                                        7


<PAGE>



Item 6. Exhibit and Reports on Form 8-K.


(a)  Exhibits:

             27.  Financial Data Schedule


(b)  Reports on Form 8-K:

             No reports on Form 8-K were filed.


























                                        8



<PAGE>



                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.





AMERICAN MEDICAL ALERT CORP.



By: /s/ Howard M. Siegel                                   Dated: August 7, 1997
    -----------------------------------
    Howard M. Siegel
    President & Chief Operating Officer



By: /s/ Corey M. Aronin
    -----------------------------------
    Corey M. Aronin
    Chief Financial Officer









                                        9